Lia C Scott1, Lee R Mobley2, Tzy-Mey Kuo3, Dora Il'yasova1. 1. Division of Epidemiology and Biostatistics, School of Public Health, Georgia State University, Atlanta, Georgia. 2. Department of Health Management and Policy, School of Public Health, Georgia State University, Atlanta, Georgia. 3. Statistics and Data Management, Cancer Information and Population Health Resource, Lineberger Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Abstract
BACKGROUND: Triple-negative breast cancer (TNBC) has been associated with a more aggressive histology, poorer prognosis, and nonresponsiveness to hormone therapy. It is imperative that cancer research identify factors that drive disparities and focus on prevention. METHODS: Using the United States Cancer Statistics database, the authors examined differences between TNBCs compared with all other breast cancers with regard to age, race/ethnicity, and stage at diagnosis. RESULTS: A total of 1,151,724 cases of breast cancer were identified from 2010 through 2014, with the triple-negative phenotype accounting for approximately 8.4% of all cases. In unadjusted analyses, non-Hispanic black women (odds ratio [OR], 2.27; 95% CI, 2.23-2.31) and Hispanic women (OR, 1.22; 95% CI, 1.19-1.25) had higher odds of diagnosis when compared with non-Hispanic white women. Women aged <40 years had the highest odds of diagnosis compared with women aged 50 to 64 years (OR, 1.95; 95% CI, 1.90-2.01). Diagnosis at American Joint Committee on Cancer stage III and beyond conferred higher odds of the diagnosis of TNBC (OR for stage III, 1.69 [95% CI, 1.68-1.72]; and OR for stage IV, 1.47 [95% CI, 1.43-1.51]). Results varied slightly in adjusted analyses. CONCLUSIONS: The results of the current study demonstrated that there is a significant burden of disease in TNBC diagnosed among women of color, specifically non-Hispanic black women, and younger women. Additional studies are needed to determine drivers of disparities between race, age, and stage of disease at diagnosis.
BACKGROUND: Triple-negative breast cancer (TNBC) has been associated with a more aggressive histology, poorer prognosis, and nonresponsiveness to hormone therapy. It is imperative that cancer research identify factors that drive disparities and focus on prevention. METHODS: Using the United States Cancer Statistics database, the authors examined differences between TNBCs compared with all other breast cancers with regard to age, race/ethnicity, and stage at diagnosis. RESULTS: A total of 1,151,724 cases of breast cancer were identified from 2010 through 2014, with the triple-negative phenotype accounting for approximately 8.4% of all cases. In unadjusted analyses, non-Hispanic black women (odds ratio [OR], 2.27; 95% CI, 2.23-2.31) and Hispanic women (OR, 1.22; 95% CI, 1.19-1.25) had higher odds of diagnosis when compared with non-Hispanic white women. Women aged <40 years had the highest odds of diagnosis compared with women aged 50 to 64 years (OR, 1.95; 95% CI, 1.90-2.01). Diagnosis at American Joint Committee on Cancer stage III and beyond conferred higher odds of the diagnosis of TNBC (OR for stage III, 1.69 [95% CI, 1.68-1.72]; and OR for stage IV, 1.47 [95% CI, 1.43-1.51]). Results varied slightly in adjusted analyses. CONCLUSIONS: The results of the current study demonstrated that there is a significant burden of disease in TNBC diagnosed among women of color, specifically non-Hispanic black women, and younger women. Additional studies are needed to determine drivers of disparities between race, age, and stage of disease at diagnosis.
Authors: Bruce G Haffty; Qifeng Yang; Michael Reiss; Thomas Kearney; Susan A Higgins; Joanne Weidhaas; Lyndsay Harris; Willam Hait; Deborah Toppmeyer Journal: J Clin Oncol Date: 2006-11-20 Impact factor: 44.544
Authors: Rebecca Dent; Maureen Trudeau; Kathleen I Pritchard; Wedad M Hanna; Harriet K Kahn; Carol A Sawka; Lavina A Lickley; Ellen Rawlinson; Ping Sun; Steven A Narod Journal: Clin Cancer Res Date: 2007-08-01 Impact factor: 12.531
Authors: Terry S Field; Diana S M Buist; Chyke Doubeni; Shelley Enger; Hassan Fouayzi; Gene Hart; Eli J Korner; Lois Lamerato; Donald J Bachman; Jennifer Ellis; Lisa Herrinton; Mark C Hornbrook; Rick Krajenta; Liyan Liu; Janice Yao Journal: J Natl Cancer Inst Monogr Date: 2005
Authors: Mary Jo B Lund; Ebonee N Butler; Harvey L Bumpers; Joel Okoli; Monica Rizzo; Nadjo Hatchett; Victoria L Green; Otis W Brawley; Gabriela M Oprea-Ilies; Sheryl G A Gabram Journal: Cancer Date: 2008-08-01 Impact factor: 6.860
Authors: Gloria J Morris; Sashi Naidu; Allan K Topham; Fran Guiles; Yihuan Xu; Peter McCue; Gordon F Schwartz; Pauline K Park; Anne L Rosenberg; Kristin Brill; Edith P Mitchell Journal: Cancer Date: 2007-08-15 Impact factor: 6.860
Authors: Lyndsay N Harris; Gloria Broadwater; Nancy U Lin; Alexander Miron; Stuart J Schnitt; David Cowan; Jonathan Lara; Ira Bleiweiss; Donald Berry; Matthew Ellis; Daniel F Hayes; Eric P Winer; Lynn Dressler Journal: Breast Cancer Res Date: 2006 Impact factor: 6.466
Authors: Marc Tischkowitz; Jean-Sébastien Brunet; Louis R Bégin; David G Huntsman; Maggie C U Cheang; Lars A Akslen; Torsten O Nielsen; William D Foulkes Journal: BMC Cancer Date: 2007-07-24 Impact factor: 4.430
Authors: Angela R Omilian; Lei Wei; Chi-Chen Hong; Elisa V Bandera; Song Liu; Thaer Khoury; Christine B Ambrosone; Song Yao Journal: Breast Cancer Res Treat Date: 2020-05-21 Impact factor: 4.872
Authors: Ahmed Adham Raafat Elsayed; Sarmad Al-Marsoummi; Emilie E Vomhof-Dekrey; Marc D Basson Journal: Cancer Genomics Proteomics Date: 2022 May-Jun Impact factor: 4.069
Authors: Nijole C Pollock; Johnny R Ramroop; Heather Hampel; Melissa A Troester; Kathleen Conway; Jennifer J Hu; Jo L Freudenheim; Olufunmilayo I Olopade; Dezheng Huo; Elad Ziv; Susan L Neuhausen; Patrick Stevens; Joseph Paul McElroy; Amanda Ewart Toland Journal: Breast Cancer Res Treat Date: 2022-03-14 Impact factor: 4.872
Authors: Aileen I Fernandez; Xue Geng; Krysta Chaldekas; Brent Harris; Anju Duttargi; V Layne Berry; Deborah L Berry; Akanksha Mahajan; Luciane R Cavalli; Balázs Győrffy; Ming Tan; Rebecca B Riggins Journal: Breast Cancer Res Treat Date: 2019-11-19 Impact factor: 4.872
Authors: Rahma S Mkuu; Idethia S Harvey; Edna Brown; Erica C Spears; Miryan G Jira; Kenne' L Johnson; Tyra Montour; Janae Alexander Journal: J Racial Ethn Health Disparities Date: 2021-02-10